Vaxcyte完成评估Vax-31预防成人侵袭性肺炎球菌病及肺炎的Opus-1与Opus-2三期临床试验患者入组

美股速递
Mar 23

Vaxcyte, Inc. 已顺利完成针对其创新疫苗Vax-31的两项关键三期临床试验——Opus-1与Opus-2——的患者招募工作。这两项试验旨在评估Vax-31在预防成人侵袭性肺炎球菌病以及肺炎方面的有效性与安全性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10